Search Results - "Blue, D.R."

Pharmacological characteristics of Ro 115–1240, a selective α1A/1L‐adrenoceptor partial agonist: a potential therapy for stress urinary incontinence by Blue, D.R., Daniels, D.V., Gever, J.R., Jett, M.F., O'Yang, C., Tang, H.M., Williams, T.J., Ford, A.P.D.W.

“…OBJECTIVE To describe the preclinical pharmacology of Ro 115–1240, a peripherally acting selective α1A/1L‐adrenoceptor (AR) partial agonist, compared with the…”
Get full text

Pharmacological characteristics of Ro 115–1240, a selective α 1A/1L ‐adrenoceptor partial agonist: a potential therapy for stress urinary incontinence by Blue, D.R., Daniels, D.V., Gever, J.R., Jett, M.F., O'Yang, C., Tang, H.M., Williams, T.J., Ford, A.P.D.W.

“…OBJECTIVE To describe the preclinical pharmacology of Ro 115–1240, a peripherally acting selective α 1A/1L ‐adrenoceptor (AR) partial agonist, compared with…”
Get full text

A randomized crossover study to evaluate Ro 115–1240, a selective α1A/1L‐adrenoceptor partial agonist in women with stress urinary incontinence by Musselman, D.M., Ford, A.P.D.W., Gennevois, D.J., Harbison, M.L., Laurent, A.L., Mokatrin, A.S., Stoltz, R.R., Blue, D.R.

“…OBJECTIVES To investigate the potential therapeutic benefits of the selective α1A/1l‐adrenoceptor partial agonist Ro 115–1240 in women with mild‐to‐moderate…”
Get full text

A randomized crossover study to evaluate Ro 115–1240, a selective α 1A/1L ‐adrenoceptor partial agonist in women with stress urinary incontinence by Musselman, D.M., Ford, A.P.D.W., Gennevois, D.J., Harbison, M.L., Laurent, A.L., Mokatrin, A.S., Stoltz, R.R., Blue, D.R.

“…OBJECTIVES To investigate the potential therapeutic benefits of the selective α 1A/1 l ‐adrenoceptor partial agonist Ro 115–1240 in women with mild‐to‐moderate…”
Get full text

Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective α1A-antagonists by LOPEZ, F. J, ARIAS, L, PADILLA, F, PEREZ-MEDRANO, A, QUINTERO, C, ROMERO, M, SANDOVAL, L, SMITH, S. A, WILLIAMS, T. J, BLUE, D. R, CHAN, R, CLARKE, D. E, ELWORTHY, T. R, FORD, A. P. D. W, GUZMAN, A, JAIME-FIGUEROA, S, JASPER, J. R, MORGANS, D. J

Get full text

Synthesis, pharmacology and pharmacokinetics of 3-(4-Aryl-piperazin-1-ylalkyl)-uracils as uroselective α 1A-antagonists by Lopez, F.J., Arias, L., Chan, R., Clarke, D.E., Elworthy, T.R., Ford, A.P.D.W., Guzman, A., Jaime-Figueroa, S., Jasper, J.R., Morgans, D.J., Padilla, F., Perez-Medrano, A., Quintero, C., Romero, M., Sandoval, L., Smith, S.A., Williams, T.J., Blue, D.R.

“…Predominance in the urethra and prostate of the α 1A-adrenoceptor subtype, which is believed to be the receptor mediating noradrenaline induced smooth muscle…”
Get full text

Functional evidence equating the pharmacologically‐defined α1A‐ and cloned α1C‐adrenoceptor: studies in the isolated perfused kidney of rat by Blue, D.R., Bonhaus, D.W., Ford, A.P.D.W., Pfister, J.R., Sharif, N.A., Shieh, I.A., Vimont, R.L., Williams, T.J., Clarke, D.E.

“…1 The present study characterizes and classifies α1‐adrenoceptor‐mediated vasoconstriction in the isolated perfused kidney of rat using quantitative receptor…”
Get full text

Functional evidence equating the pharmacologically‐defined α 1A ‐ and cloned α 1C ‐adrenoceptor: studies in the isolated perfused kidney of rat by Blue, D.R., Bonhaus, D.W., Ford, A.P.D.W., Pfister, J.R., Sharif, N.A., Shieh, I.A., Vimont, R.L., Williams, T.J., Clarke, D.E.

“…The present study characterizes and classifies α 1 ‐adrenoceptor‐mediated vasoconstriction in the isolated perfused kidney of rat using quantitative receptor…”
Get full text